Julien Ancel

549 total citations
39 papers, 356 citations indexed

About

Julien Ancel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Julien Ancel has authored 39 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Julien Ancel's work include Asthma and respiratory diseases (7 papers), Cystic Fibrosis Research Advances (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Julien Ancel is often cited by papers focused on Asthma and respiratory diseases (7 papers), Cystic Fibrosis Research Advances (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Julien Ancel collaborates with scholars based in France, Belgium and United States. Julien Ancel's co-authors include Myriam Polette, Christine Gilles, Gaëtan Deslée, Jeanne‐Marie Perotin, Valérian Dormoy, Charles Pottier, Maxime Dewolf, Béatrice Nawrocki‐Raby, Véronique Dalstein and Philippe Birembaut and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Julien Ancel

32 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Ancel France 12 140 135 131 80 30 39 356
Gonzague Delépine France 8 118 0.8× 127 0.9× 76 0.6× 44 0.6× 15 0.5× 14 293
Chen‐Chi Liu Taiwan 10 191 1.4× 97 0.7× 119 0.9× 97 1.2× 41 1.4× 15 399
Yasutaka Watanabe Japan 10 104 0.7× 159 1.2× 115 0.9× 32 0.4× 20 0.7× 39 376
Longwang Wang China 12 263 1.9× 154 1.1× 85 0.6× 114 1.4× 32 1.1× 25 461
Roy S India 10 224 1.6× 41 0.3× 103 0.8× 77 1.0× 15 0.5× 21 340
Youcef Ouadah United States 3 177 1.3× 81 0.6× 174 1.3× 47 0.6× 24 0.8× 3 339
Yiqin Zhu China 4 105 0.8× 66 0.5× 102 0.8× 79 1.0× 19 0.6× 4 219
Jie Ting Zhang China 9 171 1.2× 156 1.2× 44 0.3× 38 0.5× 30 1.0× 9 357
Jinming Zhu China 10 151 1.1× 66 0.5× 58 0.4× 94 1.2× 30 1.0× 31 323
Peng-Tao Guo China 10 111 0.8× 157 1.2× 80 0.6× 89 1.1× 24 0.8× 15 362

Countries citing papers authored by Julien Ancel

Since Specialization
Citations

This map shows the geographic impact of Julien Ancel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Ancel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Ancel more than expected).

Fields of papers citing papers by Julien Ancel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Ancel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Ancel. The network helps show where Julien Ancel may publish in the future.

Co-authorship network of co-authors of Julien Ancel

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Ancel. A scholar is included among the top collaborators of Julien Ancel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Ancel. Julien Ancel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Perotin, Jeanne‐Marie, Julien Ancel, Arnaud Bonnomet, et al.. (2025). TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients. European Journal of Immunology. 55(1). e202451480–e202451480.
4.
Perotin, Jeanne‐Marie, et al.. (2025). IgE-mediated anaphylaxis induced by pembrolizumab. Immunotherapy. 17(9). 625–629.
5.
Dewolf, Maxime, Véronique Dalstein, A. Durlach, et al.. (2025). Comparing neutrophil-to-lymphocyte ratio (NLR), absolute neutrophil count (ANC) and derived NLR as predictive biomarkers in first-line immunotherapy for non-small cell lung cancer: a retrospective study. Translational Lung Cancer Research. 14(4). 1212–1230. 1 indexed citations
6.
Petit, Laure, Julien Ancel, Gonzague Delépine, et al.. (2024). Glypican-3 is a key tuner of the Hedgehog pathway in COPD. Heliyon. 11(1). e41564–e41564. 1 indexed citations
7.
Perotin, Jeanne‐Marie, Anaëlle Muggeo, Audrey Brisebarre, et al.. (2024). High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPD. International Journal of COPD. Volume 19. 765–771.
8.
Petit, Laure, Julien Ancel, Myriam Polette, et al.. (2023). Airway ciliated cells in adult lung homeostasis and COPD. European Respiratory Review. 32(170). 230106–230106. 5 indexed citations
9.
Ancel, Julien, Valérian Dormoy, Béatrice Nawrocki‐Raby, et al.. (2023). Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors. Frontiers in Immunology. 14. 1171649–1171649. 16 indexed citations
10.
Perotin, Jeanne‐Marie, Julien Ancel, Thomas Guillard, et al.. (2023). Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis. BMC Pulmonary Medicine. 23(1). 457–457.
11.
Perotin, Jeanne‐Marie, Julien Ancel, Arnaud Bonnomet, et al.. (2022). The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients. Cells. 11(19). 2937–2937. 6 indexed citations
12.
Perotin, Jeanne‐Marie, Sophie Carré, Julien Ancel, et al.. (2022). Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients. Frontiers in Medicine. 8. 804892–804892. 5 indexed citations
13.
Perotin, Jeanne‐Marie, Julien Ancel, Gonzague Delépine, et al.. (2021). Chr15q25 Genetic Variant rs16969968 Alters Cell Differentiation in Respiratory Epithelia. International Journal of Molecular Sciences. 22(13). 6657–6657. 8 indexed citations
14.
Ancel, Julien, Jeanne‐Marie Perotin, Arnaud Bonnomet, et al.. (2021). Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD. Diagnostics. 11(9). 1579–1579. 12 indexed citations
15.
Ancel, Julien, Jeanne‐Marie Perotin, Maxime Dewolf, et al.. (2021). Hypoxia in Lung Cancer Management: A Translational Approach. Cancers. 13(14). 3421–3421. 25 indexed citations
16.
Ancel, Julien, Sandra Dury, F. Lebargy, et al.. (2021). Traitement du reflux gastro-œsophagien dans l’asthme. Revue des Maladies Respiratoires. 38(7). 733–742. 3 indexed citations
17.
Muggeo, Anaëlle, Jeanne‐Marie Perotin, Audrey Brisebarre, et al.. (2021). Extended Bacteria Culture-Based Clustering Identifies a Phenotype Associating Increased Cough and Enterobacterales in Stable Chronic Obstructive Pulmonary Disease. Frontiers in Microbiology. 12. 781797–781797. 5 indexed citations
18.
Dury, Sandra, Jeanne‐Marie Perotin, Julien Ancel, et al.. (2021). Identifying specific needs in adult cystic fibrosis patients: a pilot study using a custom questionnaire. BMC Pulmonary Medicine. 21(1). 270–270. 4 indexed citations
19.
Perotin, Jeanne‐Marie, Julien Ancel, Gonzague Delépine, et al.. (2020). Nicotinic Receptor Subunits Atlas in the Adult Human Lung. International Journal of Molecular Sciences. 21(20). 7446–7446. 16 indexed citations
20.
Ancel, Julien, Jeanne‐Marie Perotin, Sandra Dury, et al.. (2020). Sonic hedgehog signalling as a potential endobronchial biomarker in COPD. Respiratory Research. 21(1). 207–207. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026